{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:00:07Z","timestamp":1784174407020,"version":"3.55.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with GATA2 deficiency are predisposed to developing myelodysplastic neoplasms (MDS), which can progress to acute myeloid leukemia. This progression is often associated with cytogenetic and somatic alterations. Mutations in SETBP1 and ASXL1 genes are recurrently observed in GATA2 patients, although their roles remain poorly understood. Here we develop a hiPSC-based system to investigate the impact of SETBP1 and ASXL1 mutations in GATA2 deficiency. Using precise genome editing, we recreate stepwise mutational trajectories observed in GATA2-related MDS. We demonstrate that GATA2 mutation has limited impact on hematopoietic progenitors, while the co-occurrence of SETBP1 or ASXL1 mutations impairs myeloid differentiation. The combination of all three mutations severely depletes myeloid progenitors, recapitulating GATA2-related MDS and highlighting their synergistic interplay. Notably, SETBP1 mutation plays a dominant role in establishing a stable chromatin accessibility landscape, even when co-occurring with ASXL1. Our study establishes an iPSC-based model of GATA2 deficiency, offering new insights into myeloid disease progression and a platform for testing future therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41467-025-65806-9","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:02:39Z","timestamp":1763373759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6690-3363","authenticated-orcid":false,"given":"Joan","family":"Pera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9947-3577","authenticated-orcid":false,"given":"Damia","family":"Romero-Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7612-2792","authenticated-orcid":false,"given":"Eric","family":"Torralba-Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-5038","authenticated-orcid":false,"given":"Rebecca","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2328-4360","authenticated-orcid":false,"given":"Violeta","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Magallon-Mosella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Berenguer Balaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-5856","authenticated-orcid":false,"given":"Julio","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Giorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-7868","authenticated-orcid":false,"given":"Arnau","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Spurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Montserrat-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5121-2113","authenticated-orcid":false,"given":"Zhuobin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5791-1310","authenticated-orcid":false,"given":"M. Carolina","family":"Florian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-9643","authenticated-orcid":false,"given":"Marcin W.","family":"Wlodarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-6566","authenticated-orcid":false,"given":"Oskar","family":"Marin-Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-3567","authenticated-orcid":false,"given":"Alessandra","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"65806_CR1","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1093\/nar\/gks281","volume":"40","author":"EH Bresnick","year":"2012","unstructured":"Bresnick, E. H., Katsumura, K. R., Lee, H., Johnson, K. D. & Perkins, A. S. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res. 40, 5819\u20135831 (2012).","journal-title":"Nucleic Acids Res."},{"key":"65806_CR2","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1172\/JCI61623","volume":"122","author":"KD Johnson","year":"2012","unstructured":"Johnson, K. D. et al. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J. Clin. Invest. 122, 3692\u20133704 (2012).","journal-title":"J. Clin. Invest."},{"key":"65806_CR3","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1084\/jem.20130733","volume":"210","author":"X Gao","year":"2013","unstructured":"Gao, X. et al. Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J. Exp. Med. 210, 2833\u20132842 (2013).","journal-title":"J. Exp. Med."},{"key":"65806_CR4","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1182\/blood.V89.10.3636","volume":"89","author":"F-Y Tsai","year":"1997","unstructured":"Tsai, F.-Y. & Orkin, S. H. Transcription factor GATA-2 is required for proliferation\/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89, 3636\u20133643 (1997).","journal-title":"Blood"},{"key":"65806_CR5","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1084\/jem.20130751","volume":"210","author":"E de Pater","year":"2013","unstructured":"de Pater, E. et al. Gata2 is required for HSC generation and survival. J. Exp. Med. 210, 2843\u20132850 (2013).","journal-title":"J. Exp. Med."},{"key":"65806_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.stemcr.2018.05.002","volume":"11","author":"HJ Kang","year":"2018","unstructured":"Kang, H. J. et al. GATA2 is dispensable for specification of hemogenic endothelium but promotes endothelial-to-hematopoietic transition. Stem Cell Rep. 11, 197\u2013211 (2018).","journal-title":"Stem Cell Rep."},{"key":"65806_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.stemcr.2019.07.009","volume":"13","author":"J Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o, J. et al. GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm. Stem Cell Rep. 13, 515\u2013529 (2019).","journal-title":"Stem Cell Rep."},{"key":"65806_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn, C. N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012\u20131019 (2011).","journal-title":"Nat. Genet."},{"key":"65806_CR9","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","volume":"118","author":"RE Dickinson","year":"2011","unstructured":"Dickinson, R. E. et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118, 2656\u20132658 (2011).","journal-title":"Blood"},{"key":"65806_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ng.923","volume":"43","author":"P Ostergaard","year":"2011","unstructured":"Ostergaard, P. et al. Mutations in GATA2 cause with a predisposition to acute myeloid leukemia. Nat. Genet. 43, 929\u2013931 (2011).","journal-title":"Nat. Genet."},{"key":"65806_CR11","first-page":"2551","volume":"108","author":"O Marin-Bejar","year":"2023","unstructured":"Marin-Bejar, O. et al. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. Haematologica 108, 2551\u20132557 (2023).","journal-title":"Haematologica"},{"key":"65806_CR12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3324\/haematol.2022.282250","volume":"108","author":"L Largeaud","year":"2023","unstructured":"Largeaud, L. et al. Somatic genetic alterations predict hematological progression in GATA2 deficiency. Haematologica 108, 1515\u20131529 (2023).","journal-title":"Haematologica"},{"key":"65806_CR13","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski, M. W. et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood 127, 1387\u20131397 (2016).","journal-title":"Blood"},{"key":"65806_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","volume":"54","author":"MW Wlodarski","year":"2017","unstructured":"Wlodarski, M. W., Collin, M. & Horwitz, M. S. GATA2 deficiency and related myeloid neoplasms. Semin. Hematol. 54, 81\u201386 (2017).","journal-title":"Semin. Hematol."},{"key":"65806_CR15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/humu.24271","volume":"42","author":"CC Homan","year":"2021","unstructured":"Homan, C. C. et al. GATA2 deficiency syndrome: a decade of discovery. Hum. Mutat. 42, 1399\u20131421 (2021).","journal-title":"Hum. Mutat."},{"key":"65806_CR16","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","volume":"103","author":"J Donadieu","year":"2018","unstructured":"Donadieu, J. et al. Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients. Haematologica 103, 1278\u20131287 (2018).","journal-title":"Haematologica"},{"key":"65806_CR17","doi-asserted-by":"publisher","unstructured":"Kotmayer, L. et al. Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency. Blood Cancer J. https:\/\/doi.org\/10.1038\/s41408-025-01309-6 (2025).","DOI":"10.1038\/s41408-025-01309-6"},{"key":"65806_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","volume":"123","author":"MA Spinner","year":"2014","unstructured":"Spinner, M. A. et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123, 809\u2013821 (2014).","journal-title":"Blood"},{"key":"65806_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjh.18330","volume":"199","author":"L Kotmayer","year":"2022","unstructured":"Kotmayer, L. et al. GATA2 deficiency and MDS\/AML: experimental strategies for disease modelling and future therapeutic prospects. Br. J. Haematol. 199, 482\u2013495 (2022).","journal-title":"Br. J. Haematol."},{"key":"65806_CR20","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/s41375-020-0899-5","volume":"34","author":"EJ Kozyra","year":"2020","unstructured":"Kozyra, E. J. et al. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency. Leukemia 34, 2673\u20132687 (2020).","journal-title":"Leukemia"},{"key":"65806_CR21","doi-asserted-by":"publisher","first-page":"10109","DOI":"10.1073\/pnas.1813015115","volume":"115","author":"KR Katsumura","year":"2018","unstructured":"Katsumura, K. R. et al. Human leukemia mutations corrupt but do not abrogate GATA-2 function. Proc. Natl Acad. Sci. USA 115, 10109\u201310118 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65806_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1182\/bloodadvances.2021005065","volume":"6","author":"RR West","year":"2022","unstructured":"West, R. R. et al. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome. Blood Adv. 6, 793\u2013807 (2022).","journal-title":"Blood Adv."},{"key":"65806_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","volume":"20","author":"AG Kotini","year":"2017","unstructured":"Kotini, A. G. et al. Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia. Cell Stem Cell 20, 315\u2013328 (2017).","journal-title":"Cell Stem Cell"},{"key":"65806_CR24","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","volume":"28","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets. Cell Stem Cell 28, 1074\u20131089 (2021).","journal-title":"Cell Stem Cell"},{"key":"65806_CR25","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.stem.2021.03.023","volume":"28","author":"B Dannenmann","year":"2021","unstructured":"Dannenmann, B. et al. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia. Cell Stem Cell 28, 906\u2013922 (2021).","journal-title":"Cell Stem Cell"},{"key":"65806_CR26","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.scr.2021.102445","volume":"55","author":"J Castano","year":"2021","unstructured":"Castano, J., Romero-Moya, D., Richaud-Patin, Y. & Giorgetti, A. Generation of two heterozygous GATA2 CRISPR \/ Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency. Stem Cell Res. 55, 1873\u20135061 (2021).","journal-title":"Stem Cell Res."},{"key":"65806_CR27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/leu.2016.342","volume":"31","author":"V Pastor","year":"2017","unstructured":"Pastor, V. et al. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants. Leukemia 31, 759\u2013762 (2017).","journal-title":"Leukemia"},{"key":"65806_CR28","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41591-021-01511-6","volume":"27","author":"SS Sahoo","year":"2021","unstructured":"Sahoo, S. S. et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9\/ SAMD9L syndromes. Nat. Med. 27, 1806\u20131817 (2021).","journal-title":"Nat. Med."},{"key":"65806_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14785\/lpsn-2014-0022","volume":"2","author":"M Cada","year":"2015","unstructured":"Cada, M. et al. Monocytosis in a patient with a novel GATA2 mutation. LymphoSign J. 2, 85\u201390 (2015).","journal-title":"LymphoSign J."},{"key":"65806_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature11232","volume":"488","author":"RE Thurman","year":"2012","unstructured":"Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 488, 75\u201382 (2012).","journal-title":"Nature"},{"key":"65806_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0215-4","volume":"8","author":"GS Laszlo","year":"2015","unstructured":"Laszlo, G. S. et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children\u2019 s Oncology Group. J. Hematol. Oncol. 8, 1\u201310 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"65806_CR32","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41375-022-01602-4","volume":"36","author":"P Xiang","year":"2022","unstructured":"Xiang, P. et al. Elucidating the importance and regulation of key enhancers for human MEIS1 expression. Leukemia 36, 1980\u20131989 (2022).","journal-title":"Leukemia"},{"key":"65806_CR33","first-page":"1","volume":"2913","author":"M Kusakabe","year":"2019","unstructured":"Kusakabe, M. et al. Synthetic modeling reveals HOXB genes are critical for the initiation and maintenance of human. Nat. Commun. 2913, 1\u201315 (2019).","journal-title":"Nat. Commun."},{"key":"65806_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.celrep.2016.05.094","volume":"16","author":"NM Vegi","year":"2016","unstructured":"Vegi, N. M. et al. Article MEIS2 is an oncogenic partner in AML1-ETO-positive AML. Cell Rep. 16, 498\u2013507 (2016).","journal-title":"Cell Rep."},{"key":"65806_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0301-472X(01)00655-5","volume":"29","author":"T Fujino","year":"2001","unstructured":"Fujino, T., Yamazaki, Y. & Largaespada, D. A. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp. Hematol. 29, 856\u2013863 (2001).","journal-title":"Exp. Hematol."},{"key":"65806_CR36","doi-asserted-by":"publisher","first-page":"13901","DOI":"10.1073\/pnas.241525498","volume":"98","author":"SM Tanner","year":"2001","unstructured":"Tanner, S. M. et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc. Natl Acad. Sci. USA 98, 13901\u201313906 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"65806_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1182\/blood.2018862383","volume":"134","author":"S Garg","year":"2019","unstructured":"Garg, S. et al. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML. Blood 134, 263\u2013276 (2019).","journal-title":"Blood"},{"key":"65806_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2020.600227","volume":"11","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. CDK6 is a potential prognostic biomarker in acute myeloid leukemia. Front. Genet. 11, 1\u201311 (2021).","journal-title":"Front. Genet."},{"key":"65806_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-48798-8","volume":"13","author":"K Islam","year":"2023","unstructured":"Islam, K. et al. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial\u2011to\u2011mesenchymal transition of cholangiocarcinoma cells. Sci. Rep. 13, 1\u201317 (2023).","journal-title":"Sci. Rep."},{"key":"65806_CR40","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1182\/blood-2012-05-424713","volume":"121","author":"A Fantin","year":"2013","unstructured":"Fantin, A. et al. NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 121, 2352\u20132362 (2013).","journal-title":"Blood"},{"key":"65806_CR41","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ng.2696","volume":"45","author":"H Makishima","year":"2013","unstructured":"Makishima, H. et al. Somatic SETBP1 mutations in myeloid malignancies. Nat. Genet. 45, 942\u2013946 (2013).","journal-title":"Nat. Genet."},{"key":"65806_CR42","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1182\/bloodadvances.2018016501","volume":"2","author":"M Germeshausen","year":"2018","unstructured":"Germeshausen, M. et al. MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood Adv. 2, 586\u2013596 (2018).","journal-title":"Blood Adv."},{"key":"65806_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1182\/blood-2014-06-584417","volume":"125","author":"R Scheicher","year":"2015","unstructured":"Scheicher, R. et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood 125, 90\u2013101 (2015).","journal-title":"Blood"},{"key":"65806_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exphem.2018.04.007","volume":"64","author":"C Desterke","year":"2018","unstructured":"Desterke, C. et al. Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML). Exp. Hematol. 64, 71\u201383 (2018).","journal-title":"Exp. Hematol."},{"key":"65806_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2009-12-259549","volume":"117","author":"E Mahdipour","year":"2011","unstructured":"Mahdipour, E., Charnock, J. C. & Mace, K. A. Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells. Blood 117, 815\u2013826 (2011).","journal-title":"Blood"},{"key":"65806_CR46","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/sj.onc.1202498","volume":"18","author":"A Car\u00e8","year":"1999","unstructured":"Car\u00e8, A. et al. Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiation. Oncogene 18, 1993\u20132001 (1999).","journal-title":"Oncogene"},{"key":"65806_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.5498","volume":"12","author":"JY Chen","year":"2016","unstructured":"Chen, J. Y. et al. Hoxb5 marks long-term haematopoietic stem cells revealing a homogenous perivascular niche. J. Clin. Sleep. Med. 12, 263\u2013266 (2016).","journal-title":"J. Clin. Sleep. Med."},{"key":"65806_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09273-z","volume":"10","author":"P Shooshtarizadeh","year":"2019","unstructured":"Shooshtarizadeh, P. et al. Gfi1b regulates the level of Wnt\/\u00ce2-catenin signaling in hematopoietic stem cells and megakaryocytes. Nat. Commun. 10, 1\u201316 (2019).","journal-title":"Nat. Commun."},{"key":"65806_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0043300","volume":"7","author":"S Dumon","year":"2012","unstructured":"Dumon, S. et al. Itga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation. PLoS ONE 7, 1\u201312 (2012).","journal-title":"PLoS ONE"},{"key":"65806_CR50","first-page":"235","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Leukemia 471, 235\u2013239 (2011).","journal-title":"Leukemia"},{"key":"65806_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-22750-8","volume":"12","author":"E Supper","year":"2021","unstructured":"Supper, E. et al. Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia. Nat. Commun. 12, 1\u201320 (2021).","journal-title":"Nat. Commun."},{"key":"65806_CR52","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI82905","volume":"127","author":"L Gilles","year":"2017","unstructured":"Gilles, L. et al. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J. Clin. Invest. 127, 1316\u20131320 (2017).","journal-title":"J. Clin. Invest."},{"key":"65806_CR53","doi-asserted-by":"crossref","unstructured":"Thambyrajah, R. et al. GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1. Nat. Cell Biol. 18, 21\u201332 (2016).","DOI":"10.1038\/ncb3276"},{"key":"65806_CR54","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/ng.3646","volume":"48","author":"MR Corces","year":"2016","unstructured":"Corces, M. R. et al. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution. Nat. Genet. 48, 1193\u20131203 (2016).","journal-title":"Nat. Genet."},{"key":"65806_CR55","doi-asserted-by":"crossref","unstructured":"Piazza, R. et al. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub. Nat. Commun. 9, 2192 (2018).","DOI":"10.1038\/s41467-018-04462-8"},{"key":"65806_CR56","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.cell.2020.09.056","volume":"183","author":"S Ma","year":"2020","unstructured":"Ma, S. et al. Chromatin potential identified by shared single-cell profiling of RNA and chromatin. Cell 183, 1103\u20131116.e20 (2020).","journal-title":"Cell"},{"key":"65806_CR57","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","volume":"129","author":"JD Crispino","year":"2017","unstructured":"Crispino, J. D. & Horwitz, M. S. GATA factor mutations in hematologic disease. Blood 129, 2103\u20132110 (2017).","journal-title":"Blood"},{"key":"65806_CR58","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1182\/blood-2006-01-031781","volume":"109","author":"N Asou","year":"2007","unstructured":"Asou, N. et al. Brief report concurrent transcriptional deregulation of AML1 \/ RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t (8; 21)(q24; q22) acute myeloid leukemia. Blood 109, 4023\u20134027 (2007).","journal-title":"Blood"},{"key":"65806_CR59","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2009.11.001","volume":"36","author":"T Fujiwara","year":"2009","unstructured":"Fujiwara, T. et al. Article discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36, 667\u2013681 (2009).","journal-title":"Mol. Cell"},{"key":"65806_CR60","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert, K. et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086\u20131093 (2011).","journal-title":"Nat. Med."},{"key":"65806_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2023.112571","volume":"42","author":"CB Mahony","year":"2023","unstructured":"Mahony, C. B. et al. Article Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency. Cell Rep. 42, 1\u201320 (2023).","journal-title":"Cell Rep."},{"key":"65806_CR62","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/bloodadvances.2020002993","volume":"5","author":"E Gioacchino","year":"2021","unstructured":"Gioacchino, E. et al. Essential role for Gata2 in modulating lineage output from hematopoietic stem cells in zebrafish. Blood Adv. 5, 2687\u20132700 (2021).","journal-title":"Blood Adv."},{"key":"65806_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03316-w","volume":"5","author":"A Hasegawa","year":"2022","unstructured":"Hasegawa, A. et al. Heterozygous variants in GATA2 contribute to protein binding. Commun. Biol. 5, 1\u201315 (2022).","journal-title":"Commun. Biol."},{"key":"65806_CR64","first-page":"1","volume":"00","author":"E Gioacchino","year":"2024","unstructured":"Gioacchino, E. et al. GATA2 heterozygosity causes an epigenetic feedback mechanism resulting in myeloid and erythroid dysplasia. Br. J. Haematol. 00, 1\u201314 (2024).","journal-title":"Br. J. Haematol."},{"key":"65806_CR65","doi-asserted-by":"crossref","unstructured":"Largeaud, L. et al. GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 de fi ciency syndrome. Blood Cancer J. 15, 7 (2025).","DOI":"10.1038\/s41408-025-01213-z"},{"key":"65806_CR66","doi-asserted-by":"publisher","unstructured":"Hall, T. et al. Modeling GATA2 deficiency in mice: the R396Q mutation disrupts normal hematopoiesis. Leukemia 1\u201314 https:\/\/doi.org\/10.1038\/s41375-024-02508-z (2024).","DOI":"10.1038\/s41375-024-02508-z"},{"key":"65806_CR67","doi-asserted-by":"crossref","unstructured":"Abdelfattah, A. et al. Impaired DNA damage response and inflammatory signalling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency. Stem Cell Reports 20, 102596 (2025).","DOI":"10.1016\/j.stemcr.2025.102596"},{"key":"65806_CR68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1182\/blood-2024-205165","volume":"144","author":"J Fernandez Orth","year":"2024","unstructured":"Fernandez Orth, J. et al. Hematological phenotypes in GATA2 deficiency syndrome arise from secondary injuries and maladaptation to proliferation. Blood 144, 442\u2013442 (2024).","journal-title":"Blood"},{"key":"65806_CR69","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/bloodadvances.2018017137","volume":"2","author":"M Jung","year":"2018","unstructured":"Jung, M. et al. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells. Blood Adv. 2, 3553\u20133565 (2018).","journal-title":"Blood Adv."},{"key":"65806_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza, R. et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat. Genet. 45, 18\u201324 (2013).","journal-title":"Nat. Genet."},{"key":"65806_CR71","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1182\/blood.2023021349","volume":"143","author":"I Crespiatico","year":"2024","unstructured":"Crespiatico, I. et al. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood 143, 1399\u20131413 (2024).","journal-title":"Blood"},{"key":"65806_CR72","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2009-06-227363","volume":"115","author":"I Cristobal","year":"2010","unstructured":"Cristobal, I. et al. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Blood 115, 615\u2013625 (2010).","journal-title":"Blood"},{"key":"65806_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.1601602","volume":"3","author":"Z Li","year":"2017","unstructured":"Li, Z. et al. ASXL1 interacts with the cohesin complex to maintain chromatid separation and gene expression for normal hematopoiesis. Sci. Adv. 3, 1\u201311 (2017).","journal-title":"Sci. Adv."},{"key":"65806_CR74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1182\/blood-2018-99-118910","volume":"132","author":"V Pastor Loyola","year":"2018","unstructured":"Pastor Loyola, V. et al. Monosomy 7 as the initial hit followed by sequential acquisition of SETBP1 and ASXL1 driver mutations in childhood myelodysplastic syndromes. Blood 132, 105 (2018).","journal-title":"Blood"},{"key":"65806_CR75","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1038\/s41375-018-0134-9","volume":"32","author":"AF Al Seraihi","year":"2018","unstructured":"Al Seraihi, A. F. et al. GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS \/ AML. Leukemia 32, 2502\u20132507 (2018).","journal-title":"Leukemia"},{"key":"65806_CR76","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/leu.2014.301","volume":"29","author":"D Inoue","year":"2015","unstructured":"Inoue, D. et al. SETBP1 mutations drive leukemic transformation in. Leukemia 29, 847\u2013857 (2015).","journal-title":"Leukemia"},{"key":"65806_CR77","first-page":"1","volume":"2015","author":"J Buenrostro","year":"2016","unstructured":"Buenrostro, J., Wu, B., Chang, H. & Greenleaf, W. ATAC-SEQ: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 2015, 1\u201310 (2016).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"65806_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65806-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:02:43Z","timestamp":1763373763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65806"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65806-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4984522\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10035"}}